Riskpilot← Back to searchSign inGet full accessAsclepius Oy
OYDissolvedY-tunnus 2265111-1C/O Tsunami Henry Fordin Katu 4-KMedical specialists activities · NACE 8622Est. 2009— employees
Revenue 2024
EUR 197K
-18% vs 2023
EBITDA margin
166.5%
+199% vs 2023
Equity ratio
85.4%
Financial strength
Net profit 2024
EUR 53K
-39% vs 2023
| Revenue | EUR 197K | -18% |
| EBITDA | EUR 328K | +199% |
| Net profit | EUR 53K | -39% |
| Total assets | EUR 258K | +15% |
| Equity | EUR 221K | +21% |
| Employees | — | — |
Legal name
Asclepius Oy
Y-tunnus number
2265111-1
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
30. huhtikuuta 2009
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön päätoimialana on Lääkäriasemat, yksityislääkärit ja vastaavat erikoislääkäripalvelut (86220) sekä konsultointi- ja hallinnointipalvelujen tuottaminen, osakkeiden ja kiinteistöjen omistaminen ja kaupankäynti niillä, vuokraustoiminta, henkilöstövuokraus sekä muu sijoitustoiminta, kotimaassa ja ulkomailla.
Address
C/O Tsunami Henry Fordin Katu 4-K
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 224 | 209 | 241 | 197 |
| Staff expenses | — | −126 | −66 | −56 | 63 |
| EBITDA | 0 | 53 | 83 | 109 | 328 |
| Depreciation & amort. | — | −2 | −2 | −1 | 2 |
| EBIT | 0 | 51 | 81 | 108 | 64 |
| Net financials | −0 | — | −0 | −0 | — |
| Profit before tax | −0 | 51 | 81 | 108 | 66 |
| Tax | −0 | 10 | 16 | 22 | 14 |
| Net profit | 0 | 41 | 65 | 86 | 53 |
| Item | 2018 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 | 55 | 122 | 225 | 258 |
| Equity | 3 | 44 | 105 | 183 | 221 |
| Long-term debt | — | — | — | 0 | — |
| Short-term debt | 0 | 11 | 17 | 43 | 38 |
| Total debt | 0 | 11 | 17 | 43 | 38 |
EBITDA margin
166.5%
This company
15.8%
Market median
+954% vs market
20182024
Equity ratio
85.4%
This company
38.2%
Market median
+124% vs market
20182024
Return on equity
23.8%
This company
18.4%
Market median
+29% vs market
20182024
Net profit margin
26.7%
This company
8.1%
Market median
+230% vs market
20182024
Asset turnover
0.76×
This company
1.12×
Market median
-32% vs market
20182024
Debt / equity
0.17×
This company
0.62×
Market median
+73% vs market
20182024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2018Filed via PRH / YTJ · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
JW Deputy Member | Deputy Member | 2021 |
WA Chief Executive Officer | Chief Executive Officer | 2021 |
JA Deputy auditor | Deputy auditor | 2024 |
KK Audit | Audit | 2024 |
| Former (1) | ||
AP Deputy Member | Deputy Member | 2012 – 2021 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Asclepius Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Wasicki | Deputy Member | 0 companies |
| Arvi Paavo Antero Komulainen | Deputy Member | 0 companies |
| Wille Arvi Paavo Komulainen | Chief Executive Officer | 0 companies |
| Jose Adam Juhani Kautonen | Deputy auditor | 0 companies |
| Kiri Kasperi Sopanen | Audit | 0 companies |